Search research articles
Contact Us
Filters
Showing results (441-450 of 505) with videos related to
Page
of 51
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
December 17, 2020
Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis
Zhang Wang, Nicholas Locantore, Koirobi Haldar, et al.
Annals of the American Thoracic Society
|
October 27, 2020
Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT
Mark T Dransfield, Courtney Crim, Gerard J Criner, et al.
Respiratory Research
|
May 29, 2024
Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD
Phillip D Monk, Jody L Brookes, Victoria J Tear, et al.
Respiratory Medicine
|
December 5, 2022
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis
Samuel Bardsley, Gerard J Criner, David M G Halpin, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 31, 2017
Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages
Martin A Bewley, Julie A Preston, Mohammed Mohasin, et al.
Clinical Pharmacology and Therapeutics
|
December 20, 2023
A Randomized Phase I Study of the Anti-Interleukin-33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease
Fred Reid, Dave Singh, Muna Albayaty, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
November 18, 2021
Discordant diagnostic criteria for pneumonia in COPD trials: a review
Robert A Wise, Mona Bafadhel, Courtney Crim, et al.
European Journal of Preventive Cardiology
|
March 4, 2025
Identification and management of cardiopulmonary risk in patients with COPD: a multidisciplinary consensus and modified Delphi study
Chris P Gale, John R Hurst, Nathaniel M Hawkins, et al.
Respiratory Research
|
December 8, 2023
An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma
Zaid W El-Husseini, Dmitry Khalenkow, Andy Lan, et al.
The New England Journal of Medicine
|
May 20, 2024
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
Page
of 51
Search research articles
Search
Showing results (441-450 of 505) with videos related to
Sort By:
Page
of 51
American Journal of Respiratory and Critical Care Medicine
|
December 17, 2020
Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis
Zhang Wang, Nicholas Locantore, Koirobi Haldar, et al.
Annals of the American Thoracic Society
|
October 27, 2020
Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT
Mark T Dransfield, Courtney Crim, Gerard J Criner, et al.
Respiratory Research
|
May 29, 2024
Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD
Phillip D Monk, Jody L Brookes, Victoria J Tear, et al.
Respiratory Medicine
|
December 5, 2022
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis
Samuel Bardsley, Gerard J Criner, David M G Halpin, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 31, 2017
Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages
Martin A Bewley, Julie A Preston, Mohammed Mohasin, et al.
Clinical Pharmacology and Therapeutics
|
December 20, 2023
A Randomized Phase I Study of the Anti-Interleukin-33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease
Fred Reid, Dave Singh, Muna Albayaty, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
November 18, 2021
Discordant diagnostic criteria for pneumonia in COPD trials: a review
Robert A Wise, Mona Bafadhel, Courtney Crim, et al.
European Journal of Preventive Cardiology
|
March 4, 2025
Identification and management of cardiopulmonary risk in patients with COPD: a multidisciplinary consensus and modified Delphi study
Chris P Gale, John R Hurst, Nathaniel M Hawkins, et al.
Respiratory Research
|
December 8, 2023
An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma
Zaid W El-Husseini, Dmitry Khalenkow, Andy Lan, et al.
The New England Journal of Medicine
|
May 20, 2024
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
Page
of 51